Trial intelligence / Profile preview

Vildagliptin and Glucagon Response in T1D

NCT01147276Phase 4Completed

Sponsor
Lund University
Start
Sep 2010
Primary completion
Sep 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of vildagliptin in type 1 diabetes mellitus (T1D), sponsored by Lund University. Started Sep 2010; status: completed.

02

Drugs

vildagliptin
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT01147276.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01147276.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call